Cargando…
Post COVID-19 MSSA pneumonia
Coronavirus disease 2019 (COVID-19) was first identified at the end of 2019 as a cluster of pneumonia cases in Wuhan, China. By February 2020, this virus quickly spread, becoming a global pandemic. The spectrum of symptomatic infection severity can range from mild, severe, and critical disease. Many...
Autores principales: | Chaudhry, Bilal, Alekseyev, Kirill, Didenko, Lidiya, Malek, Andrew, Ryklin, Gennadiy |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8040613/ https://www.ncbi.nlm.nih.gov/pubmed/33889412 http://dx.doi.org/10.1177/2050313X211005996 |
Ejemplares similares
-
Rhinocerebral Mucormycosis and COVID-19 Pneumonia
por: Alekseyev, Kirill, et al.
Publicado: (2021) -
Longest reported case of symptomatic COVID-19 reporting positive for over 230 days in an immunocompromised patient in the United States
por: Chaudhry, Bilal, et al.
Publicado: (2021) -
A Case of Abdominal Perforation in a COVID+ Patient Treated With Tocilizumab and Corticosteroids
por: Chaudhry, Bilal, et al.
Publicado: (2023) -
Ventilator-Associated Pneumonia Due to MRSA vs. MSSA: What Should Guide Empiric Therapy?
por: Colaneri, Marta, et al.
Publicado: (2022) -
Successful management of a mediastinum abscess with sternum destruction caused by MSSA bloodstream infection
por: Wada, Hironobu, et al.
Publicado: (2022)